Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Pamidronate for the Prevention of Heterotopic Ossification
This study has been withdrawn prior to recruitment.
Study NCT00262392   Information provided by University Hospital, Basel, Switzerland
First Received: December 5, 2005   Last Updated: September 23, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Heterotopic Ossification
Additional conditions recognized in this trial
Ossification, Heterotopic
More general conditions related to this trial
Pathologic Processes
Interventions listed in this trial
Pamidronate (AREDIA)
Additional drug interventions recognized in this trial
Pamidronate
More general drug interventions related to this trial
Bone Density Conservation Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
University Hospital, Basel, Switzerland
FAG (Freie Medizinische Gesellschaft)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services